these levels have not been associated with virologic failure.11 Therefore, although this explanation for the lower percentage of women in the protease-inhibitor group with suppression to less than 50 copies per milliliter at delivery is possible, we believe it is unlikely, particularly among women who had not previously received protease inhibitors